Dosage
Typically started at 2.5 mg weekly and titrated up. Available in multiple dose strengths. Administered via subcutaneous injection once weekly.
Tirzepatide Prescription Online
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. It is the active ingredient in both Mounjaro (for diabetes) and Zepbound (for weight management).


Tirzepatide uniquely activates both GIP and GLP-1 receptors, providing enhanced glycemic control and weight loss compared to single-receptor agonists. Clinical trials showed superior A1C reduction and weight loss.
Not for emergencies. Plunge Care is not for emergencies. If you're experiencing a medical emergency, call 911.
Clinician-led decisions. All treatment decisions are made by the reviewing licensed provider. Plunge Care does not guarantee any specific prescription or outcome.
Typically started at 2.5 mg weekly and titrated up. Available in multiple dose strengths. Administered via subcutaneous injection once weekly.
Common side effects include nausea, diarrhea, decreased appetite, vomiting, and constipation. Serious risks include pancreatitis and thyroid tumors.
Create your account and share a brief health history.
Submit your request through your secure patient portal.
A licensed provider in your state reviews your request.
If appropriate, your prescription or order is sent to your pharmacy or lab.
